Sinus delivery of sustained release therapeutics
    2.
    发明授权
    Sinus delivery of sustained release therapeutics 有权
    持续释放治疗药物的窦炎

    公开(公告)号:US07544192B2

    公开(公告)日:2009-06-09

    申请号:US10800162

    申请日:2004-03-12

    IPC分类号: A61M31/00

    摘要: The invention provides biodegradable implants for treating sinusitis. The biodegradable implants have a size, shape, density, viscosity, and/or mucoadhesiveness that prevents them from being substantially cleared by the mucociliary lining of the sinuses during the intended treatment period. The biodegradable implants include a sustained release therapeutic, e.g., an antibiotic, a steroidal anti-inflammatory agent, or both. The biodegradable implants may take various forms, such as rods, pellets, beads, strips, or microparticles, and may be delivered into a sinus in various pharmaceutically acceptable carriers.

    摘要翻译: 本发明提供用于治疗鼻窦炎的可生物降解植入物。 可生物降解的植入物具有尺寸,形状,密度,粘度和/或粘膜粘附性,防止在预期治疗期间鼻窦的粘膜纤毛内衬基本上被清除。 可生物降解的植入物包括持续释放治疗剂,例如抗生素,甾族抗炎药或两者。 可生物降解的植入物可以采取各种形式,例如棒,丸,珠,条或微粒,并且可以递送到各种药学上可接受的载体中的窦内。

    Sinus delivery of sustained release therapeutics
    5.
    发明授权
    Sinus delivery of sustained release therapeutics 有权
    持续释放治疗药物的窦炎

    公开(公告)号:US08109918B2

    公开(公告)日:2012-02-07

    申请号:US12479794

    申请日:2009-06-06

    IPC分类号: A61M31/00

    摘要: The invention provides biodegradable implants for treating sinusitis. The biodegradable implants have a size, shape, density, viscosity, and/or mucoadhesiveness that prevents them from being substantially cleared by the mucociliary lining of the sinuses during the intended treatment period. The biodegradable implants include a sustained release therapeutic, e.g., an antibiotic, a steroidal anti-inflammatory agent, or both. The biodegradable implants may take various forms, such as rods, pellets, beads, strips, or microparticles, and may be delivered into a sinus in various pharmaceutically acceptable carriers.

    摘要翻译: 本发明提供用于治疗鼻窦炎的可生物降解植入物。 可生物降解的植入物具有尺寸,形状,密度,粘度和/或粘膜粘附性,防止在预期治疗期间鼻窦的粘膜纤毛内衬基本上被其清除。 可生物降解的植入物包括持续释放治疗剂,例如抗生素,甾族抗炎药或两者。 可生物降解的植入物可以采取各种形式,例如棒,丸,珠,条或微粒,并且可以递送到各种药学上可接受的载体中的窦内。

    Sinus delivery of sustained release therapeutics
    6.
    发明授权
    Sinus delivery of sustained release therapeutics 有权
    持续释放治疗药物的窦炎

    公开(公告)号:US07691094B2

    公开(公告)日:2010-04-06

    申请号:US12419937

    申请日:2009-04-07

    IPC分类号: A61M31/00

    摘要: The invention provides biodegradable implants for treating sinusitis. The biodegradable implants have a size, shape, density, viscosity, and/or mucoadhesiveness that prevents them from being substantially cleared by the mucociliary lining of the sinuses during the intended treatment period. The biodegradable implants include a sustained release therapeutic, e.g., an antibiotic, a steroidal anti-inflammatory agent, or both. The biodegradable implants may take various forms, such as rods, pellets, beads, strips, or microparticles, and may be delivered into a sinus in various pharmaceutically acceptable carriers.

    摘要翻译: 本发明提供用于治疗鼻窦炎的可生物降解植入物。 可生物降解的植入物具有尺寸,形状,密度,粘度和/或粘膜粘附性,防止在预期治疗期间鼻窦的粘膜纤毛内衬基本上被其清除。 可生物降解的植入物包括持续释放治疗剂,例如抗生素,甾族抗炎药或两者。 可生物降解的植入物可以采取各种形式,例如棒,丸,珠,条或微粒,并且可以递送到各种药学上可接受的载体中的窦内。